European health authorities have Galvus approved as a new oral treatment for type 2 diabetes patients, paving the way for launches in Europe. This approval is valid in all 27 EU countries plus Norway and Iceland and comes after changes updating the EU label Novartis Novartis regarding the administration of Galvus.

The Riley Safety Store is a blueprint for children’s hospitals trained nationally with 11 children’s hospitals were to safety store start in the last two years by Riley Hospital Safety Store Team in cooperation with the National Association of Children’s Hospitals and Related Institutions. Hospitals, Jro are trained:.Continue reading